Metiprajlon

Metiprilon
Klinički podaci


Prodajno ime	Dimerin, Noctan, Nodular, Noludar
Drugs.com	Monografija
Farmakokinetički podaci
Poluvreme eliminacije	6-16 h

Identifikatori
CAS broj	125-64-4^Y
ATC kod	N05CE02 (WHO)
PubChem	CID 4162
DrugBank	DB01107^Y
ChemSpider	4018^Y
ChEMBL	CHEMBL1200790^Y
Hemijski podaci
Formula	C₁₀H₁₇NO₂
Molarna masa	183,248
SMILES CCC1(CC)C(=O)NCC(C)C1=O
InChI InChI=1S/C10H17NO2/c1-4-10(5-2)8(12)7(3)6-11-9(10)13/h7H,4-6H2,1-3H3,(H,11,13)^Y Key:SIDLZWOQUZRBRU-UHFFFAOYSA-N^Y

Metiprajlon, ili Noludar, je sedativ porodice derivata piperidindiona koji je prvi razvilo preduzeće Hofman-La Roš.^[1] Ovaj lek se koristio za lečenje nesanice, ali se sada retko koristi, jer su ga zamenili noviji lekovi sa manje neželjenih efekata, kao što su benzodiazepini.^[2]

Osobine

Metiprilon je organsko jedinjenje, koje sadrži 10 atoma ugljenika i ima molekulsku masu od 183,248 Da.^[3]^[4]^[5]^[6]^[7]

Osobina	Vrednost
Broj akceptora vodonika	2
Broj donora vodonika	1
Broj rotacionih veza	2
Particioni koeficijent^[8] (ALogP)	1,5
Rastvorljivost^[9] (logS, log(mol/L))	-1,8
Polarna površina^[10] (PSA, Å²)	46,2

Reference

^ US granted 2680116, Frick H, Lutz AH, "Piperidiones and Process for the Manufacture thereof", issued 1954-06-01, assigned to Hoffmann-La Roche
^ Lomen P, Linet OI (1976). „Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients”. The Journal of International Medical Research. 4 (1): 55—8. PMID 16792. S2CID 12500779. doi:10.1177/030006057600400108.
^ Contos DA, Dixon KF, Guthrie RM, Gerber N, Mays DC: Nonlinear elimination of methyprylon (noludar) in an overdosed patient: correlation of clinical effects with plasma concentration. J Pharm Sci. 1991 Aug;80 (8): 768–71. PMID 1686463
^ Gwilt PR, Pankaskie MC, Thornburg JE, Zustiak R, Shoenthal DR: Pharmacokinetics of methyprylon following a single oral dose. J Pharm Sci. 1985 Sep;74 (9): 1001–3. PMID 2866242
^ Lomen P, Linet OI: Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients. J Int Med Res. 1976;4 (1): 55–8. PMID 16792
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126. уреди
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958. уреди
^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t. уреди
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e. уреди

Literatura

Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Anvisa (31. 03. 2023). „RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial” [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (на језику: португалски). Diário Oficial da União (објављено 2023-04-04). Архивирано из оригинала 03. 08. 2023. г. Приступљено 16. 08. 2023.

Spoljašnje veze

Methyprylon

Hipnotici/sedativi (N05C)

GABA_A receptor

Barbiturati

Ultra kratkotrajni	Metoheksital Tiamilal Tiopental
Kratko/srednje trajni	Alobarbital Amobarbital Aprobarbital Butobarbital Pentobarbital Sekobarbital Talbutal
Dugotrajni	Barbital Mefobarbital Fenobarbital
Negrupisani	Ciklobarbital Etalobarbital Heptabarbital Heksobarbital Proksibarbital Reposal Vinilbital Vinbarbital

Benzodiazepini

Kratkotrajni	Brotizolam Cinolazepam Doksefazepam Loprazolam Midazolam Triazolam
Intermedijerno trajni	Estazolam Flunitrazepam Lormetazepam Nimetazepam Temazepam
Dugotrajni	Flurazepam Flutoprazepam Nitrazepam Kvanzepam

Dialkil-fenoli

Nebenzodijazepini

Piperidindioni

Hinazolinoni

Neuroaktivni steroidi

Alfa-2-adrenergički
receptor

Alfa-adrenergički agonisti	4-NEMD Klonidin Deksmedetomidin Lofeksidin Medetomidin Romifidin Tizanidin Ksilazin

Melatoninski receptor

Melatonin	Agomelatin Melatonin Ramelteon Tasimelteon

Histaminski receptor &
Acetilholinski receptor

Antihistamini & Antiholinergici	Amitriptilin Demenhidranat Doksilamin Hidroksizin Difenhidramin Bromodifenhidramin Karbinoksamin Doksepin Esmirtazapin Orfenadrin Mianserin Mirtazapin Finiltoloksamin Propiomazin Pirilamin Skopolamin

5-HT_2A &
α₁- adrenergički

Selektivni 5-HT_2A & α₁-adrenergički antagonisti	Etoperidon Nefozodon Niaprazin Trazodon

GABA_B receptor /
GHB receptor

GHB Tip	1,4-Butandiol Acebuterna keselina GABAB Gama-hidroksibuterna kiselina GBL gama-Balerolakton

Oreksinski receptori

Oreksinski antagonisti	Almoreksant SB-334,867 SB-408,124 SB-649,868 TCS-OX2-29

Drugi receptori/
negrupisani

Aldehidi	Acetilglicinamid hloral hidrat Hloral hidrat Hloralodol Dihloralfenazon Paraldehid Petrihloral
Alkini	Centalun Ethlorvinon Etinamat Heksapropimat Metilpentinol
Karbamati	Meprobamat Karisoprodol Tibamat Metokarbamol Procimat
Drugi	2-Metil-2-butanol Acekarbromal Acetofenon Apronal Bromidi Bromizoval Karbromal Hloralosa Klometiazol Embutramid Etomidat Evoksin Fenadiazol Gaboksadol Loreklezol Mefenoksalon Sulfonmetan Trihloroetanol Triklofos Valerian Valnoktamid